Orum Therapeutics Announces $30 Million Series B Financing to Advance Cell-Penetrating, Cell-Specific Antibody Technology for Novel Therapeutics

from Venture Capital Access Online: Latest Venture Capital and Private Equity News https://ift.tt/2LWS5D9
via IFTTT